# Biomedical Technology Holdings

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biomedical-technology-holdings

- Industry: Biotechnology
- Headquarters: Hongkong, China
- Website: biomed.hk
- Total disclosed funding: $2M
- Latest round: Seed (Apr 20, 2023)
- Investors on record: 3

## About

Established in 2018 and based in Hongkong, Biomedical Technology Holdings Limited operates as a gut health solutions provider that provides gut microecological health management solutions. The company has a medical treatment center, and research and testing center. It has received PIC/S GMP certification, FSSC22000 (food safety system), ISO22000 (food safety management system) and HACCP (hazard analysis critical control point) certification. The CEO, Tsang Chi Hin, was the founder of Proactive Technology Limited. In April 2023, the company raised USD 2 million in seed funding led by Alibaba Entrepreneurs Fund. In April 2024, Biomedical Technology Holdings Limited completed a strategic investment from new investor Chinese University of Hong Kong.

Biomedical Technology Holdings Limited offers biome health management solutions and products, including gut microbiome testing, microbial DNA testing and customised probiotic products. Its products include PGut Probiotic E3, PGut Immunovitamin and PGut Probiotic E3, etc. The company also provides probiotic-based personalized intestinal therapy solutions.

The company generates revenue by offering the gut microbiome testing, microbial DNA testing and customised probiotic products.

## Funding rounds

- Seed, Apr 20, 2023, $2M — Gobi Partners, Alibaba Entrepreneurs Fund, The International Medical Co. Ltd.

## Investors

- Gobi Partners (https://capitalatlas.ai/funds/gobi-partners) — Seed
- Alibaba Entrepreneurs Fund (https://capitalatlas.ai/funds/alibaba-entrepreneurs-fund) — Seed
- The International Medical Co. Ltd. — Seed